PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33834359-6 2021 Moreover, we confirm of therapeutic effects of GB1107, a cell-penetrating galectin-3 specific inhibitor, using orthotopic gastric cancer-bearing mice RESULTS: Increased levels of galectin-3 and STAT3 phosphorylation were detected in the stomach tissues of WNT1-overexpressing mouse models. GB1107 47-53 lectin, galactose binding, soluble 3 Mus musculus 74-84 33834359-6 2021 Moreover, we confirm of therapeutic effects of GB1107, a cell-penetrating galectin-3 specific inhibitor, using orthotopic gastric cancer-bearing mice RESULTS: Increased levels of galectin-3 and STAT3 phosphorylation were detected in the stomach tissues of WNT1-overexpressing mouse models. GB1107 47-53 lectin, galactose binding, soluble 3 Mus musculus 179-189 33834359-10 2021 GB1107, a specific membrane-penetrating inhibitor of galectin-3, significantly reduced the activation of both STAT3 and beta-catenin and inhibited tumor growth in orthotopic gastric cancer-bearing mice. GB1107 0-6 lectin, galactose binding, soluble 3 Mus musculus 53-63 33834359-12 2021 Therefore GB1107, a galectin-3-specific inhibitor, maybe a potent agent with anti-gastric cancer activity. GB1107 10-16 lectin, galactose binding, soluble 3 Mus musculus 20-30